Safety, Pharmacodynamics, and Pharmacokinetics of Orally Administered BLD-2660 in Subjects With IPF

Clinical trial NCT04244825 · WITHDRAWN

Trial details

NCT number: NCT04244825
Sponsor: Blade Therapeutics
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2019-12-15
Primary completion: 2020-09-14
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.